SOUTHERN JOURNAL OF SCIENCES

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematological malignancy predominantly affecting individuals under 20 years of age. Traditional chemotherapy, such as clofarabine, has shown efficacy; however, novel immunotherapeutic strategies like tisagenlecleucel (Kymriah®) have significantly altered the treatment paradigm. Aim: This study aimed to perform a comparative analysis of tisagenlecleucel, a CAR-T cell therapy, and clofarabine, a second-generation purine nucleoside analog, evaluating their mechanisms of action, therapeutic benefits, limitations, and clinical applicability across diverse patient populations. Methods: A systematic comparative evaluation was conducted, encompassing pharmacological characteristics, mechanisms of action, treatment protocols, efficacy, safety profiles, and clinical indications of both agents. The analysis considered pharmacokinetic and pharmacodynamic data and included patient demographic variables. Results: Tisagenlecleucel demonstrated high efficacy in refractory B-cell ALL, with durable responses and a blood half-life of 128 days, but with notable immune-related adverse effects such as cytokine release syndrome. Clofarabine, effective across a broader patient population, acts via multiple antitumor mechanisms but carries significant toxicity risks, including infection and sepsis. Discussion: The therapies present distinct clinical profiles: tisagenlecleucel offers targeted immunotherapy with high specificity but requires specialized infrastructure and management of immune toxicities. Clofarabine is more widely accessible and applicable, but is associated with conventional chemotherapy-related side effects. Treatment accessibility and cost differ markedly between the two. Conclusions: Therapy selection should be personalized based on patient-specific factors and institutional resources. Tisagenlecleucel is ideal for pediatric and young adult patients with relapsed/refractory B-cell ALL in CAR-T-capable centers, while clofarabine remains a viable option for broader ALL populations, particularly when genetic therapies are not feasible. Further research is needed to optimize therapeutic strategies and improve access to advanced treatments.

During the construction of concrete structures of small cross-sections, the release of heat during cementhardening has no harmful effects. With the increasing temperature of the hardening cement mass, the rate ofcement hydration increases. This increases the rate of release of its heat of hydration of cement. Theconsequence of the accelerated process of hydration of the binder is a more intensive increase in the strengthof cement stone than in the case of hardening under normal conditions. This fact is widely used in practice forthe intensification of the hardening of concrete. When structures with small cross-sections are being built, theheat released during hardening is relatively quickly transferred to the surrounding space and does not cause asignificant increase in temperature. In structures made of massive concrete (with a large cross-section), thisheat is stored in the interior of the array for a long time, which causes a rather large rise in temperature and itsslow drop. This is due to the fact that heat transfer to the external environment is hampered here by theconsiderable thickness of the massif and the rapid rate of concreting, mechanized laying of large masses ofconcrete. As a result, a temperature difference is created between the internal and external parts of thestructure and harmful internal stresses arise that can cause cracking in the hardened concrete. This leads to aviolation of its solidity. The faster cement hydrates, the sooner and more heat is released. The types of cementswith a high content of tricalcium silicate and aluminate emit more heat and rather than types of cement with ahigh content of dicalcium silicate and tetra-calcium aluminoferrite. However, the latter has a lower strength. Theincrease in strength resulting from the hydration process is inevitably associated with the release of heat into theenvironment. C

Sand casting is a viable waste as an alternative raw material, regarding a good solution in the production of concrete blocks. The use of sand casting to produce concrete blocks is performed by about 80% of the productive capacity of the company considered in this study. Thus, this work aims to make an improvement by applying fuzzy logic. The methodology was applied from the formulation of ranking criteria, which improved the production process. Therefore, after the implementation of the established criteria, was achieved an improvement of about 10%. Thus, the results achieved can help companies, generating alternatives with more excellent reliability and assertiveness. Moreover, Fuzzy is a methodology that provides strong support for decision making, supporting subjective and intuitive criteria.